Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Open-label 1-year extension study of pitavastatin 4 mg once daily in hypercholesterolemia or combined dyslipidemia
2005-001112-41Phase 3Completed
- Sponsor
- Kowa Research Europe
- Start
- Jan 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of pitavastatin in hypercholesterolemia and combined dyslipidaemia, sponsored by Kowa Research Europe. Primary endpoint: Long-term safety and tolerability. Started Jan 2006; status: completed.
02
Drugs
pitavastatin
03
Conditions
hypercholesterolemiacombined dyslipidaemia
Beyond the preview
Go deeper on 2005-001112-41.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-001112-41.